Domestic pharma companies enjoy a 77 per cent share of the (IPM), and this share has been consistently above 74 per cent in the past four years or so. What’s more, when it comes to growth rates, Indian companies have been steadily beating the multinational pharma players hands down for the past many years, and industry insiders believe that the trend is unlikely to reverse anytime soon.

As per data culled from the AIOCD-AWACS, the market research wing of All India Organisation of Chemists and Druggists (AIOCD), the association representing over 500,000 medicines sellers across India, in terms of growth in (MAT) value, while the IPM clocked a 11.4 per cent growth in March 2013 over March 2012, the Indian pharma companies grew by 12.6 per cent whereas the firms clocked 7.9 per cent.

For more details click here.